Jarosław Król, president of Polfa Tarchomin, highlights the strategic moves he has made to stabilise the company and the need to deliver a new, fresh portfolio to drive forward profit. Furthermore, he highlights the company’s future path of being a EU certified API supplier and the importance of an economic background in the world of generics. You have been recently appointed president of Polfa Tarchomin. What are current priorities on your agenda?
"We want to enrich further our API production expertise and the University of Warsaw has excellent competencies in the area of chemical and biological processes engineering."